بیوگرافی دکتر مسعود قاسمی

متخصص بیماری های قلب و عروق
فلوشیپ فوق تخصصی آنژیوگرافی وآنژیوپلاستی
رئیس انجمن آترواسکلروز ایران

Personal Information
Name: Massoud Ghasemi

Date of Birth: 26.02.1960

 

Education
Doctorate of Medicine, Faculty of Medicine, Tehran University, Tehran, Iran. 1986

Residency & Postdoctoral Training
Department of Cardiology, Faculty of Medicine, Tehran ♦
University. Tehran, Iran. 1986-1991 ♦

Fellowship in Interventional Cardiology, Faculty of Medicine ♦

Tehran, University. Tehran, Iran  1991-1992

Interventional Cardiology Profession


Current Positions
 Chairman of Iranian Society of Atherosclerosis
 President of the International Congress of Cardiovascular Updates
 Consultant, Interventional Cardiologist, Attending Cardiologist, Imam Khomeini Medical Center, Tehran University of Medical Sciences. Tehran, Iran
 Director, Research Center of Endovascular Intervention & President of International Meeting of Cardiovascular Updates
 Director, Cardiac Catheterization and Interventional Cardiology, Payambaran Hospital. Tehran, Iran
 Director, Cardiac Catheterization and Interventional Cardiology, Laleh Hospital. Tehran, Iran
 Director, Cardiac Catheterization and Interventional Cardiology, Sasan Hospital. Tehran
 Chairman of Arya Atherosclerosis Journal
 Executive Director of Endovascular Journal (official Journal of Research Center of Endovascular Intervention)
 Head of scientific committee, BAM Riding school
 Director, Cardiac Catheterization and Interventional Cardiology, Bahman Hospital. Tehran
 Iran’s representative in WHO for non-communicable diseases (Influenza prevention in high risk population)
 Interventional Cardiologist of Pars Hospital. Tehran, Iran

Professional Memberships
 American College of Cardiology (ACC)
 Asian Pacific Society of Cardiology (FCAPSC)
 New York Academy of Science
 European Atherosclerosis Association
 International Society of Endovascular Specialists
 Iranian Heart Association
 Iranian Society of Atherosclerosis
 Research Center of Endovascular Intervention
 Working group on Interventional Cardiology of the European Society of Cardiology

Scientific/Managerial Activities

 Fellow of American College of Cardiology (FACC)

 Fellow of Asian Pacific Society of Cardiology (FCAPSC)

 Fellow of Tehran University of Medical Sciences, 1992-Current

 Dyslipidemia Advisory board, Feb 2017, Amgen, Tehran, Iran

 Hypertension Advisory board; Novartis, Nov, 2017, Tehran, Iran

 FOURIER Advisory Board; Amgen, Dec 2017, Tehran , Iran

 Cardiology Advisory board, MERCK, Dec 2017, Rome, Italy

 President, Heart & New Technology Meeting (February 28- March3rd, 2006 Ramsar)

 Member of scientific committee of The First Congress of Cardiovascular Updates (1998-2003, Tehran)

 Vice President of the Fifth Congress of Cardiovascular Updates (June 2004, Tehran)

 President of first symposium in stem cell and cardiovascular Disease

 Active member in fundament of the first cardiovascular research animal laboratory in Tehran University

Certifications and Trainings
 Certified fellow of American College of Cardiology, since 2018
 Certified fellow and member of Asian Pacific Society of Cardiology (FCAPSC)
 12th International Symposium on catheter ablation techniques, Paris, France, 3-5 Oct 2018
 Minimalist TF – TAVI training seminar, By Prof Alain Cribier, Rouen ,France, 14 – 16 May 2017
 Updates of TAVI training, George Pompidu Hospital, Paris, France, April 2017
 Winner of the First Prize for the “Most Educational Case at the CIT 2006
 Certification of Endovascular Intervention (Cerebrovascular and peripheral), Scripps Clinic, California, USA. 2003
 Certification of Interventional Cardiology, Royal Brompton & Harefield Hospital, London, 1996
 Certification of Interventional Cardiology, the Royal Marsden, 1994
 NHS Trust, London.UK. , 1994
 Certification of Interventional Cardiology, France, 1993

Research Projects & Grants Funding
 Active researcher in survey of stem cell transplantation for repair of myocardial infarction (April 2004-Current)
 Active researcher in survey of detection of mutations in patients with hypertrophic cardiomyopathy
 Researcher of foundation of the stem cell preparation laboratory in Sasan Hospital
 Main investigator: Registry of assessment of PCI use in STEMI and NSTEMI patients in Iran , 2017

 Main investigator in Persian Driver Registry (2004-2005)
 Main Investigator in the Family of Endeavor Persian Registry-FAVOR I &II (2005-2008)
 Main Investigator in the Xience V Persian Registry (2007-2008)

Scientific and Professional Publications
– Thesis
 Structural Heart Diseases Based on Congenital Heart Diseases (in referral patients to Tehran university hospital) . MD Degree, Tehran University, Iran.1986
 Midterm results of PTCA compared to coronary artery bypass graft and medical treatment Fellowship Dissertation, Tehran University, Tehran, Iran.1992

Published papers
 Mehrpooya M1 *, Ghasemi M1 , Gerayeli B1 , Sherafati A2 and Dashti S3 : Acute Abdominal Aortic Dissection during Invasive Coronary Assessment in a Patient with Glucose-6- Phosphate Dehydrogenase Deficiency, Austin Publishing Group ,Published: September 05, 2022.
 P Sadeghipour, H Babakhani, S Abdi, M Ghasemi, J Moosavi, M Sadeghian, O Shafe, B Mohebbi :
Diagnostic accuracy of two-dimensional coronary angiographic derived fractional flow reserve, European Heart Journal, Volume 41, Issue Supplement_2, November 2020, Published:25 November 2020
 Hamid Babakhani MS, Parham Sadeghipour MD, Ahmad Tashakori Beheshti MD, Massoud Ghasemi MD, Jamal Moosavi MD, Mohamad Sadeghian MD, Mahmood Salesi PhD, Ali Zahedmehr MD, Omid Shafe MD, Farshad Shakerian MD, Bahram Mohebbi MD, Mohammad Javad Alemzadeh-Ansari MD, Ata Firouzi MD, Babak Geraiely MD, Seifollah Abdi MD: Diagnostic accuracy of two-dimensional coronaryangiographic-derived fractional flow reserve—Preliminaryresults , Catheter Cardiovasc Interv. 2020;1–11.
 M.Ghasemi, Sense of impending doom during angioplasty for patients also interventionists, 2017
 M.Ghasemi: One –stage angioplasty and stenting of ostium of left common carotid artery and stenting of left internal carotid artery in an 81-years-old man with transient ischemic attackActa Medica Iranica, Vol.55, No. 1،2017
 M.Ghasemi : Autologous Adult Stem Cell Transfusion In Chronic Revascularized Patients Including Post PCI and Post CABG Conditions – 2015
 M.Ghasemi , M Mehrpoya: Redo percutaneous mitral valvuloplasty (Redo PMV) in patients with recurrent mitral valve stenosis: Immediate and early outcomes-2015
 M.Ghasemi , P.Ghazi, M.Zarghampour, A.Haji-zeinali : Transcatheter stent implantation for the treatment of abdominal Aortic Coarctation and right renal artery stenosis in Takayasu`s arteries ; A case with a 4 years followup. Hellenic Journal of cardiology, 2011
 Arash Mohammadi Tofigh, M Ghasemi, Babak Heidari Aghdam, Mersedeh Karvandi , Afsoon Kaboli :
Endovascular treatment of thoracoabdominal aortic aneurysm: a case report. Journal of Medical Case Reports, 2010.
 M. Ghasemi, Hashemi Fesharaki, M. Sanatkar: Basilar artery angioplasty and stenting. European Journal of Vascular and Endovascular Surgery, 2006.
 M. Ghasemi, M. Sanatkar: The Arterial Stiffness Index (ASI) and risk of restenosis. Tehran, Iranian Heart Journal, 2004.
 M. Ghasemi, N. Naderi, M. Sanatkar: Effects of intravenous immunoglobulin treatment on patients with chronic heart failure, Delhi, Indian Heart Journal, 2004.
 M. Ghasemi, E. Nematipour, N. Naderi, M. Sanatkar : Safety and efficacy of redo percutaneous Mitral valvuloplasty (PMV).Delhi, Indian Heart Journal, 2004.

 M. Essalat, S.H.Mirkhani, M.Ghasemi, M.Sanatkar, R. Zarezadeh: Atherosclerosis of the internal mammary artery in patients undergoing coronary artery bypass grafting. Tehran, Iranian ACTA Medica Journal, Vol 14, No3, 2003.
 M. Ghasemi: Incidence of infective endocarditis caused by dentistry. Tehran, Journal of Azad Islamic, 2000.
 M. Ghasemi: Analysis of the abundance of heart types throughout angioplasty. Tehran, Journal of Iran University, 2000.
 M. Ghasemi: Angioplasty and the types of disease. Tehran, Journal of Iran University,2000.
 M. Ghasemi: Results of Mitral valve valvaloplasty. Tehran, Journal of Medical Council of Islamic Republic of Iran, 1996.
 M.Ghasemi : New intervention Technology in treatment of Cerebro-vascular disease ,First congress on Novel Approaches of biomedical engineering in cardiovascular disease; Iran
 M. Ghasemi: Hydatic cyst in the heart. Journal of Medical Council of Islamic republic of Iran, 1992.
 M. Ghasemi: Prevention of hypertension. Tehran, Journal of basic science of Iran, 1992.
 M. Ghasemi: Atherosclerosis of coronary artery. Tehran, Journal of Basic Science of Iran,1992.
 M. Ghasemi: Role of X-ray in diagnosis of cardiovascular disease. Tehran, Journal of Basic Science of Iran, 1993.
 M. Ghasemi: Technology in medicine. Tehran, Journal of Basic Science of Iran, 1993.
 M. Ghasemi: Anemia and hydatid cyst of the heart. Tehran, Iranian ACTA Medical Journal,1992.
 M. Ghasemi: ATP and the heart. Tehran, Iranian ACTA Medical Journal, 1989.
 M. Ghasemi: Results of new method (MGH) in Phrenic nerve. Tehran, Journal of Faculty of Medicine, 1987.
 M. Ghasemi: Results of catheterism in congenital heart disease. Tehran, Journal of Faculty of Medicine, 1987

Presentations / Invitational Lectures
 How to Future-Proof Aortic Endovascular Repair Webinar, Tehran, Iran, September 2022.
 Heart & Kidney: Focus on clinical management of cardiovascular disease in CKD & ESRD patients, Symposium,Theran, Iran, August 2022.
 Invited Speaker,(AHS) Asian Cardiovascular Clinical Research Seminar (Virtual) ,Beijing, China , June 2022.
 Invited Speaker, Daily Cardiology Virtual Symposium,Theran, Iran, June 2022.
 Invited Speaker and Chairman; HEART TALKS: Your Beat, Your Story, Istanbul, Turkey, June 2022.
 Chairman; Novel Management Of Heart Failure Symposium,Theran, Iran, May 2022.
 Cardiologists and Endocrinologists Overcoming Type2 Diabetes Webinar, Tehran, Iran, February 2022.
 Hypertension treatment in special situations and heart failure Webinar, Tehran, Iran, February 2022.
 Blood Pressure Guidelines Webinar, Tehran, Iran, December 2021.
 The HEART Truth: Hypertension Matters Webinar, Tehran, Iran, November 2021.
 The Effect of Combination Drugs on Blood Pressure Webinar, Tehran, Iran, October 2021.
 A Bright Journey Through Antithrombotic Therapy in SCAF & Strok Webinar, Tehran, Iran, October 2021.
 Heart Failure Treatment:The Fantastic Four Webinar, Tehran, Iran, August 2021.
 Potent Antiplatelet Therapy Webinar, Tehran, Iran, August 2021.
 Cardiologist & Endocrinologist Overcoming Type 2 Diabetes (CEO Masterclass III)Webinar, Tehran, Iran, August 2021.
 New Generation of ARBs Webinar, Tehran, Iran, July 2021.
 Heart and Antiplatelets Webinar, Tehran, Iran, June 2021.
 Cardiologist & Endocrinologist Overcoming Type 2 Diabetes(CEO Masterclass II) Webinar, Tehran, Iran, April 2021.
 Optimizing P2Y12 inhibitor therapy in different types of patients: what happens in practice Webinar, Tehran, Iran, March 2021.

 14th Annual Seminar of Interventional Cardiology Focus on Complications , Tehran, Iran, Feb 2021.
 Cardiologist & Endocrinologist Overcoming Type 2 Diabetes (CEO Masterclass I)Webinar, Tehran, Iran, Feb 2021.
 Cardiometabolic Diseases Management Challenges & Advances Webinar, Tehran, Iran, Jan 2021.
 Medical Treatment of Ischemic Heart Hisease Hocusing on beta-blockers and Ethylene Nitrates Webinar, Tehran, Iran, Dec 2020.
 Ticagrelor as a Potent Antiplatelet Agent Webinar, Tehran, Iran, Dec 2020.
 Role of ARBs in hypertension management Webinar, Tehran, Iran, Nov 2020.
 Chairman; 12th Middle East Cardiovascular Congress (MECC)&5th Clinical Cases in Complex Cardiovascular Therapy (CCCCT) Shiraz, Iran , Nov 2020.
 New Data And Recent Advances In Antiplatelet Agents Webinar, Tehran, Iran, Oct 2020.
 NOACs from coronary syndromes to cardiac arrhythmias Webinar, Tehran, Iran, Oct 2020.
 Cardiovascular Diseases Prevention; Risk Factors Management (Lipid & Hypertension) Webinar, Tehran, Iran, Sep 2020.
 From Hypertension to Heart Failure , Contemporary Updates Webinar, Tehran, Iran, Aug 2020.
 Hypercholesterolemia Management in ASCVD Patients Webinar, Tehran, Iran, July 2020.
 Role of Beta blockers in Management of Coronary Artery Disease Webinar , Tehran, Iran, July2020.
 Essential Updates on Hypertension from Guideline to Office Webinar, Tehran, Iran, June 2020.
 The latest updates on managing patients with” Coronary Artery Disease” Webinar, Tehran, Iran, May 2020.
 Invited Speaker, The Role of Emerging Technologies in Interventional Procedures, Anesthesia Congress, Razi Conference Center, Dec 2019
 Chairman; Hypertension & Heart Failure Treatments and Challenges Symposium, Evin Hotel, Theran, Iran, Dec 2019
 Guest Faculty; Dyslipidemia Symposium, Imam Khomeini Hospital, Tehran, Iran Dec 2019
 Invited Speaker & Chairman; Cased- base discussion on stroke, Heart of Stroke Symposium, Evin Hotel, Tehran, Iran, Dec 2019
 Chairman; 3rd Iranian PCR, Shahid Rajaee Hospital Conference Hall, Nov 2019
 Invited Speaker and Chairman; Heart Core Assembly 4, Fisherman Bastion Gate, Budapest, Hungary, June 2019.
 Chairman; Iranian Stroke Congress, National Library Conference Hall, Tehran , Iran, Feb 2019,
 Chairman; Inflammation in arteries, Congress of Arterial Inflammation with Approach to Immunology and Inflammatory diseases, Feb 2019
 Invited Speaker; Stent selection and in-stent thrombosis (with emphasis on personal medicine aspects), Interventional Cardiology Congress, Rajaee Medical Research Center, Tehran, Iran, Feb 2019.
 Invited Speaker and panel member; Iran’s status in non-communicable diseases, 1st national congress of Non-communicable diseases prevention, Talash Complex, Tehran, Iran, Jan 2019.
 Chairman and invited speaker; The latest guideline on ACS, Evin Hotel, Tehran, Iran, Jan 2019.
 Invited Speaker and panel member, Complex cardiac cases, 12th annual seminar on interventional cardiology, Rajaee Medical Research Center, Tehran, Iran, Jan 2019.
 Invited Speaker; Case presentation on CTO, Iran CTO Meeting , In Collaboration with EURO CTO CLUB, TOBI, EBC, Dec, 2018
 Invited speaker; OCT Imaging, Understanding of Basics, Imam Khomeini Hospital, Nov 2018.
 Chairman, Updates of Antiplatelet therapy, Rajaee Medical Research Center, Dec 2018.
 Invited Speaker; Tavi vs CABG, 2nd Iranian Congress on Acute Coronary Syndromes, Tabriz, Iran, June 2018.
 Invited speaker; Flue in High Risk Groups, National Annula Flue Congress, Espinal Conference Hall, Oct,2018
 Invited Speaker; Possible Technical Maneuvers to Reduce Al Post Evolut, 1st advanced TAVI training, Istanbul, Turkey, Oct 2018.
 Invited Speaker, Individualize Therapy vs Guidelines, 3rd Near East Cardiologist Standalone Meeting Heart Core Assembly & 12th International Symposium on Catheter Ablation Techniques, , Paris, France, Oct 2018.

REFERENCES
 Dr Charles D.J. Ilsey. Director of cardiology, Harefield Hospital Hill End Road, Middlesex, UB9 6JH, London.UK
 Dr. A. Mitchell. Consultant cardiologist, Harefield Hospital. Hill End Road Middlesex, UB9 6JH, London.UK
 Dr. V. Paul. Consultant cardiologist, Harefield Hospital. Hill End Road Middlesex, UB9 6JH, London.UK

 Dr B. Valeix. Ancien assistant des hôspital. Chef de clinique cardiologique a la faculté médicine des hospital, France.
 M. Saeed. Head, Division of Vascular Radiology. Scripps clinic, La Jolla, California, USA
 Dr. Paul S.Teirstein. Head, Department of Cardiology. Scripps clinic, La Jolla, California, USA